Seasonal influenza vaccine efficacy and its determinants in children and non-elderly adults: a systematic review with meta-analyses of controlled trials (Q38059026)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Seasonal influenza vaccine efficacy and its determinants in children and non-elderly adults: a systematic review with meta-analyses of controlled trials	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

0 references

Seasonal influenza vaccine efficacy and its determinants in children and non-elderly adults: a systematic review with meta-analyses of controlled trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

0 references

0 references

systematic review

1 reference

based on heuristic

inferred from title

influenza vaccine

1 reference

based on heuristic

inferred from title

Stanley Plotkin

3

object named as

Stanley Plotkin

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

author name string

Carlos A DiazGranados

1

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Martine Denis

2

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

language of work or name

0 references

publication date

7 November 2012

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

31

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

49-57

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Seasonal influenza vaccine provision in 157 countries (2004-2009) and the potential influence of national public health policies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.084

7 January 2021

Mortality associated with influenza and respiratory syncytial virus in the United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.084

7 January 2021

Influenza-associated hospitalizations in the United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.084

7 January 2021

The annual impact of seasonal influenza in the US: Measuring disease burden and costs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.084

7 January 2021

The socio-economic burden of influenza

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.084

7 January 2021

Challenge of conducting a placebo-controlled randomized efficacy study for influenza vaccine in a season with low attack rate and a mismatched vaccine B strain: a concrete example

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.084

7 January 2021

Safety, efficacy, and immunogenicity of an inactivated influenza vaccine in healthy adults: a randomized, placebo-controlled trial over two influenza seasons

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.084

7 January 2021

Efficacy studies of influenza vaccines: effect of end points used and characteristics of vaccine failures

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.084

7 January 2021

Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.084

7 January 2021

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.084

7 January 2021

Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.084

7 January 2021

Efficacy of inactivated split-virus influenza vaccine against culture-confirmed influenza in healthy adults: a prospective, randomized, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.084

7 January 2021

A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.084

7 January 2021

Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.084

7 January 2021

Comparative efficacy of inactivated and live attenuated influenza vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.084

7 January 2021

Prevention of symptomatic seasonal influenza in 2005-2006 by inactivated and live attenuated vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.084

7 January 2021

Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.084

7 January 2021

Clinical Trials with Alice Strain, Live, Attenuated, Serum Inhibitor-Resistant Intranasal Influenza A Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.084

7 January 2021

Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.084

7 January 2021

The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.084

7 January 2021

Evaluation of live attenuated influenza vaccines in children 6-18 months of age: safety, immunogenicity, and efficacy. National Institute of Allergy and Infectious Diseases, Vaccine and Treatment Evaluation Program and the Wyeth-Ayerst ca Influenza

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.084

7 January 2021

Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.084

7 January 2021

Effects of influenza plus pneumococcal conjugate vaccination versus influenza vaccination alone in preventing respiratory tract infections in children: a randomized, double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.084

7 January 2021

Placebo-controlled double-blind clinical studies on the efficacy of different influenza vaccines assessed by experimental and natural infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.084

7 January 2021

Correlated Studies of a Recombinant Influenza-Virus Vaccine. IV. Protection against Naturally Occurring Influenza in Military Trainees

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.084

7 January 2021

Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.084

7 January 2021

A controlled trial of inactivated monovalent influenza A vaccines in general practice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.084

7 January 2021

Field trial of live attenuated influenza A/B ("Alice"/R-75) vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.084

7 January 2021

Efficacy, safety, and immunogenicity of a Vero-cell-culture-derived trivalent influenza vaccine: a multicentre, double-blind, randomised, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.084

7 January 2021

Clinical efficacy of cell culture–derived and egg‐derived inactivated subunit influenza vaccines in healthy adults.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.084

7 January 2021

Efficacy and safety of a live attenuated, cold-adapted influenza vaccine, trivalent against culture-confirmed influenza in young children in Asia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.084

7 January 2021

Oil-in-water emulsion adjuvant with influenza vaccine in young children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.084

7 January 2021

Safety, efficacy, and effectiveness of cold-adapted influenza vaccine-trivalent against community-acquired, culture-confirmed influenza in young children attending day care

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.084

7 January 2021

Influenza A virus vaccines containing purified recombinant H3 hemagglutinin are well tolerated and induce protective immune responses in healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.084

7 January 2021

Protective efficacy of a trivalent recombinant hemagglutinin protein vaccine (FluBlok®) against influenza in healthy adults: a randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.084

7 January 2021

Immunogenicity of 1967 polyvalent and 1968 Hong Kong influenza vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.084

7 January 2021

Responses to one or two doses of a deoxycholate subunit influenza vaccine in a primed population

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.084

7 January 2021

Evaluation of an attenuated, cold-recombinant influenza B virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.084

7 January 2021

Evaluation of a Neuraminidase-Specific Influenza A Virus Vaccine in Children: Antibody Responses and Effects on Two Successive Outbreaks of Natural Infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.084

7 January 2021

Efficacy of sequential annual vaccination with inactivated influenza virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.084

7 January 2021

Comparison of heterotypic protection against influenza A/Taiwan/86 (H1N1) by attenuated and inactivated vaccines to A/Chile/83-like viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.084

7 January 2021

Efficacy and safety of a live attenuated influenza vaccine in adults 60 years of age and older

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.084

7 January 2021

Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.084

7 January 2021

Heterogeneity and statistical significance in meta-analysis: an empirical study of 125 meta-analyses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.084

7 January 2021

Immunogenicity and Safety of 2 Dose Levels of a Thimerosal-Free Trivalent Seasonal Influenza Vaccine in Children Aged 6-35 Months: A Randomized, Controlled Trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.084

7 January 2021

Cross-protection against homologous drift variants of influenza A and B after vaccination with split vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.084

7 January 2021

Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.084

7 January 2021

Antibody response against heterogeneous circulating influenza virus strains elicited by MF59- and non-adjuvanted vaccines during seasons with good or partial matching between vaccine strain and clinical isolates.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.084

7 January 2021

Cross-reactive antibodies in middle-aged and elderly volunteers after MF59-adjuvanted subunit trivalent influenza vaccine against B viruses of the B/Victoria or B/Yamagata lineages

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.084

7 January 2021

The need for quadrivalent vaccine against seasonal influenza

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.084

7 January 2021

Superior Relative Efficacy of Live Attenuated Influenza Vaccine Compared With Inactivated Influenza Vaccine in Young Children With Recurrent Respiratory Tract Infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.084

7 January 2021

Sensitivity, specificity, and vaccine efficacy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.084

7 January 2021

A prospective, randomized, open-label trial comparing the safety and efficacy of trivalent live attenuated and inactivated influenza vaccines in adults 60 years of age and older

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.084

7 January 2021

Controlled trial of inactivated influenza vaccine containing the a-Hong Kong strain during an outbreak of influenza due to the a-England-42-72 strain

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.084

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2012.10.084

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38059026&oldid=1775320645"